Cargando…

Corrigendum to: Edoxaban in AF patients with PCI by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882362/ https://www.ncbi.nlm.nih.gov/pubmed/33351101 http://dx.doi.org/10.1093/eurheartj/ehaa987

Ejemplares similares

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial
por: Vranckx, Pascal, et al.
Publicado: (2020)

Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
Publicado: (2019)

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis
por: Goette, Andreas, et al.
Publicado: (2020)

Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study
por: Valle, Felipe H., et al.
Publicado: (2021)

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)
por: De Caterina, Raffaele, et al.
Publicado: (2019)

Pre-PCI angina post-PCI ischaemia: tales of ordinary madness
por: Marzilli, Mario, et al.
Publicado: (2019)

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
por: Baldus, Stephan, et al.
Publicado: (2023)

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT‐AF/VTE)—Trial design
por: Colonna, Paolo, et al.
Publicado: (2018)

Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database
por: Chen, Cathy, et al.
Publicado: (2023)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Mechanical circulatory support in high-risk PCI and acute coronary syndrome
por: Pappalardo, Federico, et al.
Publicado: (2017)

IVUS-guided versus OCT-guided PCI among patients presenting with acute coronary syndrome
por: Abdelmonaem, Mostafa, et al.
Publicado: (2023)

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
por: Kato, Eri Toda, et al.
Publicado: (2016)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

The Application of Rotational Atherectomy in PCI of Coronary Chronic Total Occlusions
por: Zhang, Bin, et al.
Publicado: (2016)

PCI-to-PCI bridge architecture specification: Revision 1.1
por: PCI Special Interest Group. Portland, OR, USA
Publicado: (1998)

AFS Monitoring: The CERN AFS Console
por: Wiebalck, Arne
Publicado: (2008)

Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE
por: Santamaria, Amparo, et al.
Publicado: (2023)

Before Coronary CTO PCI: Burden or Location?
por: Choi, Woong Gil
Publicado: (2022)

VHDL design of PCI mezzanines (PMC) for a PCI-SCI bridge
por: Fernández, C, et al.
Publicado: (1995)

Mug{AF}amar{AF}at Farn{AF}ats{AF}i == Farnatchi au bal masqué == Farnatchi at the masked ball /
por: Fayard, Roland
Publicado: (1997)

PCI Week Conference
Publicado: (1995)

PCI system architecture
por: Shanley, Tom, et al.
Publicado: (1995)

PCI system architecture
por: Shanley, Tom, et al.
Publicado: (1999)

PCI bus demystified
por: Abbott, Doug
Publicado: (2004)

PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017)

CTO in Contemporary PCI
por: Farag, Mohamed, et al.
Publicado: (2022)

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
por: Fanola, Christina L., et al.
Publicado: (2018)

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study
por: de Vries, T. A. C., et al.
Publicado: (2021)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program
por: Chao, Tze-Fan, et al.
Publicado: (2023)

Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres: Sub-group analysis of the ELISA-3 trial
por: Badings, E. A., et al.
Publicado: (2016)

The future of angiography: Estimates of FFR pre‐ and post‐PCI
por: Tehrani, David M., et al.
Publicado: (2022)

PCI compliance: understand and implement effective PCI data security standard compliance
por: Williams, Branden R, et al.
Publicado: (2015)

PCI Compliance: Understand and Implement Effective PCI Data Security Standard Compliance
por: Chuvakin, Anton, et al.
Publicado: (2010)

PCI-X addendum to the PCI local bus specification: Revision 1.0
por: PCI Special Interest Group. Portland, OR, USA
Publicado: (1999)

PCI Compliance: Understand and Implement Effective PCI Data Security Standard Compliance
por: Bradley, Tony
Publicado: (2007)

PCI compliance: understand and implement effective PCI data security standard compliance
por: Williams, Branden R, et al.
Publicado: (2012)

Overophedning af partikelaccelerator var frygtet af forskere
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fdjprtldkc5u9m7hlviipr3m73